No Detail Found!

Role of the CHA2DS2VASc Score as a short-term clinical predictor in chronic kidney disease patients undergoing regular hemodialysis

Author(s)
M. Feldi Gazaly Department of Internal Medicine, Division of Nephrology and Hypertension, Faculty of Medicine,Universitas Sumatera Utara,Indonesia
Bayu Rusfandi Nasution Department of Internal Medicine, Division of Nephrology and Hypertension, Faculty of Medicine,Universitas Sumatera Utara,Indonesia
Abstract
Objective: To evaluate the role of the CHA2DS2-VASc score as a short-term clinical predictor in chronic kidney disease (CKD) patients undergoing regular haemodialysis. Methodology: This retrospective cohort study analysed CKD patients undergoing regular haemodialysis at a tertiary hospital in Medan, Indonesia. Patients were categorized into low (0-1), moderate (2-3), and highrisk (4-9) groups based on their CHA2DS2-VASc scores. One-year mortality was the primary outcome, assessed using survival analysis and multivariate regression. Results: Higher CHA2DS2-VASc scores =4 were associated with older age, increased comorbidities, and elevated inflammatory markers. Survival analysis showed a significant correlation between higher scores and increased mortality risk (HR 5.602, p<0.001), although multivariate analysis did not identify independent pre-dictors of mortality. Laboratory findings varied across risk groups, with significant differences in CRP, uric acid, and calcium levels. Conclusion: The CHA2DS2-VASc score may serve as a useful tool for mortality risk stratification in haemo-dialysis patients. However, its predictive value remains uncertain due to study limitations, including a single-centre design and small sample size. Further research with larger cohorts and additional biomarkers is needed to enhance its clinical applicability in CKD populations.
Publication Details
Page(s) 596-600
DOI DOI not available
Published Journal: Rawal Medical Journal, Volume: 50, Issue: 3, Year: 2025

Request the full text from PASTIC

Keywords
Chronic kidney disease, Hemodialysis, mortality risk., CHA2DS2VASC score
References
Lv JC,Zhang LX,Liu BC,Lan HY,Lv LL .2019 .Prevalence and Disease Burden of Chronic Kidney Disease. Renal Fibrosis: Mechanisms and Therapies, : 3-15.
Rai NK,Wang Z,Drawz PE,Connett J,Murphy DP .2023 .CKD Progression Risk and Subsequent Cause of Death: A Population-Based Cohort Study. Kidney Med, 5 : 100604.
Francis A,Harhay MN,Ong ACM,Tummalapalli SL,Ortiz A,Fogo AB .2024 .chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol, 20 : 473-85.
Badan .2018 .Penelitian dan Pengembangan Kementerian Kesehatan Repubik Indonesia. Laporan Nasional Riset Kesehatan Dasar, : .
Badan .2013 .Penelitian dan Pengembangan Kementerian Kesehatan Repubik Indonesia. Laporan Nasional Riset Kesehatan Dasar, : .
Chen LY,Norby FL,Chamberlain AM,MacLehose RF,Bengtson LGS,Lutsey PL,Hispanics. Stroke PL .2019 .-VASc Score and Stroke Prediction in Atrial Fibrillation in Whites, Blacks, and. , 50 : 28-33.
Pramudyo M,Putra ICS,Pratama FB,Pranata R .2023 .Usefulness of The CHADS2 and CHA2DS2-VASc Scores in Predicting In-Hospital Mortality in Acute Coronary Syndrome Patients: A Single-Center Retrospective Cohort Study. Ind J Cardiol, 44 : 17-27.
Siddiqi TJ,Usman MS,Shahid I,Ahmed J,Khan SU,Ya'qoub L SU .2022 .Utility of the CHA2DS2-VASc score for predicting ischaemic stroke in patients with or without atrial fibrillation: a systematic review and meta-analysis. Eur J Prev Cardiol, 29 : 625-31.
Okubo A,Doi T,Morii K,Nishizawa Y,Yamashita K,Shigemoto K .2022 .Utility of CHA2DS2-VASc Score to Predict Mid-Term Clinical Outcomes in Hemodialysis Patients. Am J Nephrol, 53 : 169-75.
Abrantes AM,Marques da Silva B,Branco C,Costa C,Peres N,Cardoso A .2023 .One-Year Mortality after Hemodialysis Initiation: The Prognostic Role of the CHA2DS2- VASc Score. J Clin Med, 12 : 1011-6.
Pravda MS,Hagai KC,Topaz G,Pravda NS,Makhoul N,Shuvy M .2020 .Assessment of the CHA2DS2-VASc Score in Predicting Mortality and Adverse Cardiovascular Outcomes of Patients on Hemodialysis. Am J Nephrol, 51 : 635-40.
Wu Y,Gao Y,Li Q,Wu C,Xie E,Tu Y .2022 .9. Front Cardiovasc Med, : .
Goudis C,Daios S,Korantzopoulos P,Liu T.,Does T. .2021 .CHA2- DS2-VASc score predict mortality in chronic kidney disease?. Intern Emerg Med, 16 : 1737-42.
Zhang J,Lenarczyk R,Marin F,Malaczynska-Rajpold K,Kosiuk J,Dohner W .2023 .The interpretation of CHA2- DS2-VASc score components in clinical practice: a joint survey by the European Heart Rhythm Association (EHRA) Scientific Initiatives Committee, the EHRA Young Electrophysiologists, the Association of Cardiovascular Nursing and Allied Professionals, and the European Society of Cardiology Council on Stroke. EP Europace, 23 : 314-22.
Parsons C,Patel SI,Cha S,Shen WK,Desai S,Chamberlain AM .2017 .The CHA2DS2-VASc Score A Predictor of Thromboembolic Events and Mortality In Patients With an Implantable Monitoring Device Without Atrial Fibrillation. Mayo Clin Proc, 92 : 360-9.
Vodošek Hojs N,Ekart R,Bevc S,Piko N,Hojs R. .2021 .CHA2DS2-VASc Score as a Predictor of Cardiovascular and All-Cause Mortality in Chronic Kidney Disease Patients. Am J Nephrol, 52 : 404-11.
Wang L,Gong X,Sun G,Jiang A,Li B,Wang B .2022 .CHADS2 and CHA2DS2-VASc scores in evaluating the prognosis of maintenance hemodialysis patients. Research Square, : .
0

Citations

0

Downloads

44

Views